tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Indaptus Therapeutics Inc

INDP
Add to Watchlist
3.170USD
+0.020+0.63%
Close 11-13 16:00（ET）
486.85MMarket Cap
LossP/E TTM

Indaptus Therapeutics Inc

3.170
+0.020+0.63%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

INDP Financials

See Indaptus Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
486.85M
Dividend TTM
0.00
P/E TTM
-0.25
EPS TTM
-12.81
Revenue
--
Net Profit
-15.02M
ROE
-931.79%
ROA
-496.74%
Indaptus Therapeutics Inc Earnings Date
Latest Release
Nov 13, 2026
EPS / Forecast
-0.01/-1.46
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
99.74%-0.01
99.83%-0.02
97.42%-0.23
57.36%-4.51
66.98%-2.98
30.88%-9.09
28.72%-9.00
20.64%-10.59
30.88%-9.04
-21.67%-13.16
10.94%-12.63
-7.82%-13.34
---13.07
---10.82
---14.18
---12.37
----
----
----
----
Net Profit
64.75%-1.05M
65.67%-1.79M
43.94%-2.54M
-96.38%-8.11M
3.06%-2.98M
-30.23%-5.23M
-19.07%-4.53M
-3.20%-4.13M
21.76%-3.07M
-23.73%-4.02M
10.50%-3.81M
-9.49%-4.00M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
-449.48%-3.37M
9.93%-3.22M
Debt to assets ratio
----
----
----
----
----
--95.08%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Operating profit
57.11%-1.14M
59.41%-1.81M
52.77%-2.16M
-95.51%-8.16M
15.71%-2.65M
-8.47%-4.46M
-15.96%-4.57M
0.19%-4.17M
26.04%-3.14M
-17.56%-4.11M
11.49%-3.94M
-2.27%-4.18M
-19.59%-4.25M
9.67%-3.50M
-30.95%-4.46M
-26.99%-4.09M
-5.48%-3.55M
-631.92%-3.87M
-454.11%-3.40M
9.18%-3.22M
Net Profit
64.75%-1.05M
65.67%-1.79M
43.94%-2.54M
-96.38%-8.11M
3.06%-2.98M
-30.23%-5.23M
-19.07%-4.53M
-3.20%-4.13M
21.76%-3.07M
-23.73%-4.02M
10.50%-3.81M
-9.49%-4.00M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
-449.48%-3.37M
9.93%-3.22M
Balance Sheet
Current assets
----
86.93%11.99M
-56.04%2.18M
40.67%9.31M
-15.60%6.44M
-14.36%6.41M
-51.80%4.96M
-52.71%6.62M
-54.70%7.63M
-62.32%7.49M
-53.54%10.29M
-48.63%14.00M
-43.08%16.84M
-40.27%19.87M
-40.00%22.15M
-32.54%27.24M
-32.52%29.59M
77.06%33.27M
203.64%36.92M
169.82%40.39M
Total current liabilities
----
-92.77%615.43K
-64.28%933.00K
81.46%6.16M
0.08%2.23M
341.51%8.51M
69.90%2.61M
22.34%3.39M
-5.61%2.23M
-8.32%1.93M
-15.65%1.54M
-19.20%2.77M
-17.90%2.37M
-41.97%2.10M
-50.47%1.82M
-25.43%3.43M
-50.16%2.88M
-33.38%3.62M
-29.28%3.68M
-13.68%4.60M
Total assets
356.31%31.21M
75.28%11.99M
-59.70%2.18M
26.86%9.31M
-16.99%6.84M
-15.79%6.84M
-50.57%5.41M
-50.83%7.34M
-53.69%8.24M
-61.04%8.12M
-52.70%10.95M
-46.82%14.92M
-41.57%17.79M
-38.80%20.84M
-37.59%23.14M
-30.84%28.06M
-30.57%30.45M
69.52%34.06M
112.77%37.09M
94.18%40.58M
Total liabilities
834.50%20.88M
-92.77%615.43K
-64.28%933.00K
81.46%6.16M
-0.10%2.23M
335.29%8.51M
64.48%2.61M
19.19%3.39M
-9.10%2.24M
-11.88%1.96M
-18.95%1.59M
-17.07%2.85M
-14.74%2.46M
-39.23%2.22M
-47.48%1.96M
-26.59%3.43M
-50.08%2.89M
-40.68%3.65M
-38.71%3.73M
-26.50%4.68M
Total equity
124.33%10.33M
779.62%11.37M
-55.43%1.25M
-20.11%3.15M
-23.28%4.61M
-127.14%-1.67M
-70.09%2.80M
-67.33%3.94M
-60.85%6.00M
-66.89%6.17M
-55.82%9.36M
-50.97%12.08M
-44.38%15.33M
-38.75%18.63M
-36.49%21.19M
-31.39%24.63M
-27.61%27.57M
118.19%30.41M
194.04%33.36M
147.02%35.90M
Cash Flow Statement
Net operating income
44.04%-1.44M
52.03%-1.93M
-38.89%-7.01M
6.04%-3.19M
-2.16%-2.57M
-62.16%-4.02M
-28.21%-5.05M
-30.51%-3.40M
32.71%-2.51M
-17.62%-2.48M
20.67%-3.94M
-17.69%-2.60M
18.84%-3.73M
33.08%-2.11M
-59.16%-4.96M
37.54%-2.21M
-1200.53%-4.60M
-143.15%-3.15M
-277.64%-3.12M
-33.57%-3.54M
Net investment
--0.00
---4.00M
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
338.17%7.00M
150.60%8.00M
176.50%2.14M
1033.64%5.12M
-76159.86%-2.94M
-718506.23%-15.81M
---2.80M
7626.67%451.60K
Net financing
816.52%20.49M
90.68%11.98M
----
225.92%5.87M
-13.76%2.24M
16411.32%6.28M
897.13%3.15M
--1.80M
--2.59M
--38.06K
--316.05K
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
411.35%363.06K

FAQs

What are the current assets of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its current assets were 9.31M, with a year-on-year change of 40.67.

What are the total assets of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its total assets of Indaptus Therapeutics Inc were 9.31M, with a year-on-year change of 26.86.

What are the total liabilities of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its total liabilities of Indaptus Therapeutics Inc were 6.16M, with a year-on-year change of 81.46.

What is the total equity of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its total equity of Indaptus Therapeutics Inc was 3.15M, with a year-on-year change of -20.11.

What is the net operating income of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its net operating income of Indaptus Therapeutics Inc was -19.83M, with a year-on-year change of -29.08.

What is the net financing of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its net financing of Indaptus Therapeutics Inc was 17.54M, with a year-on-year change of 269.51.

What is the Earnings Per Share (EPS) of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -21.58, with a year-on-year change of 52.00.

What is the net income of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its net income was -20.85M, with a year-on-year change of -38.79.

What is the Return on Equity (ROE) of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -588.41, with a year-on-year change of -213.78.

What is the Return on Assets (ROA) of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -250.45, with a year-on-year change of -85.59.

What is the operating profit of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its operating profit was -19.83M, with a year-on-year change of -29.08.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy